GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $212,000 | 0.0% | 4,861 | 0.0% | 0.07% | +21.7% |
Q1 2022 | $212,000 | +1827.3% | 4,861 | +1844.4% | 0.06% | +1900.0% |
Q4 2021 | $11,000 | +10.0% | 250 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $10,000 | 0.0% | 250 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $10,000 | 0.0% | 250 | -11.7% | 0.00% | 0.0% |
Q1 2021 | $10,000 | 0.0% | 283 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $10,000 | -9.1% | 283 | 0.0% | 0.00% | -25.0% |
Q3 2020 | $11,000 | 0.0% | 283 | 0.0% | 0.00% | -20.0% |
Q2 2020 | $11,000 | +1000.0% | 283 | +757.6% | 0.01% | +400.0% |
Q1 2020 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $1,000 | -99.9% | 33 | -99.9% | 0.00% | -99.9% |
Q3 2017 | $1,013,000 | -9.3% | 24,950 | -3.7% | 0.67% | -9.9% |
Q2 2017 | $1,117,000 | +2.3% | 25,900 | 0.0% | 0.74% | -5.1% |
Q1 2017 | $1,092,000 | +19.3% | 25,900 | +9.0% | 0.78% | +7.2% |
Q4 2016 | $915,000 | – | 23,755 | – | 0.73% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |